Liver steatosis adverse outcome pathway (WP4010)
Homo sapiens
This liver steatosis AOP starts from the top with different molecular initiating events going down towards liver steatosis. The black nodes are Key Events and green nodes are molecular pathways. Adverse outcome pathway liver steatosis; the accumulation of lipids in hepatocytes, caused either by over-nutrition, visceral obesity, metabolic syndrome, or environmental toxins. Liver steatosis can be divided into three main categories: alcoholic liver disease (ALD), non-alcoholic liver disease (NAFLD), and toxicant-associated liver disease (TAFLD).[https://pubmed.ncbi.nlm.nih.gov/28210688/ Review on liver steatosis]
Authors
JJv Heijden , Alex Pico , Marvin Martens , Jeroen Kearns , Chesley De Windt , Eric Weitz , and Finterly HuActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
Adverse Outcome PathwaysAnnotations
Cell Type Ontology
hepatocyteDisease Ontology
fatty liver disease| Label | Type | Compact Identifier | Comment |
|---|